TBA · NSE,BSE · Medical Equipment & Supplies
Integris Medtech IPO is scheduled to open from 27 Nov 2026 to 01 Dec 2026 . The Mainboard IPO has a price band of TBA , with a minimum lot size of TBA . Allotment is expected on 02 Dec 2026 and listing on 04 Dec 2026 .
Integris Medtech IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 27 Nov 2026 |
| IPO Close Date | 01 Dec 2026 |
| Basis of Allotment | 02 Dec 2026 |
| Initiation of Refunds | 03 Dec 2026 |
| Credit of Shares to Demat | 03 Dec 2026 |
| Listing Date | 04 Dec 2026 |
Issue Size
[.]
Issue Price
[.]
Face Value
₹1/share
Market Lot
[.]
Retail Min Investment
[.]
Listing At
NSE,BSE
Sale Type
both
Fresh Issue
₹600 Cr
Offer for Sale
[.]
Issue Type
book building
Open Date
27 Nov
Close Date
01 Dec
Allotment
02 Dec
Listing
04 Dec
No snapshot available yet.
Evercure Holdings Pte.Ltd., Medicore Holdings Pte.Ltd., Gurmit Singh Chugh and Punita Sharma.
Integris Medtech Limited was incorporated as Integris Health Private Limited on April 25, 2008, was renamed Integris Medtech Private Limited on June 30, 2025, and became a public limited company on August 8, 2025. Its registered office is in New Delhi and its corporate office is in Noida, Uttar Pradesh. It works in the medical devices and laboratory solutions sector.
The company develops, manufactures and sells medical products across three areas: cardiovascular devices, clinical diagnostics and scientific laboratory solutions. It operates three manufacturing facilities in Dehradun, and one facility each in Chennai, the Netherlands and Germany. As of June 30, 2025, its operations extended to over 65 countries, and it had 1,879 employees on a consolidated basis. The company is promoted by Evercure Holdings Pte. Ltd., Medicore Holdings Pte. Ltd., Gurmit Singh Chugh and Punita Sharma.
This is a mainboard IPO, proposed to be listed on the BSE and NSE. As per the DRHP, the issue comprises a fresh issue of equity shares aggregating up to Rs 925 crore, along with an offer for sale of up to 2,16,74,531 equity shares by existing shareholders. Proceeds from the fresh issue are proposed to be used for repayment of borrowings, with the balance for general corporate purposes. ICICI Securities Limited, Axis Capital Limited, Citigroup Global Markets India Private Limited and IIFL Capital Services Limited are the book running lead managers, and KFin Technologies Limited is the registrar of the issue. The price band has not yet been announced.
Standalone · ₹ in Crores
| Particulars | FY Mar 2023 | FY Mar 2024 | FY Mar 2025 |
|---|---|---|---|
| Total Revenue | 1,369.66 | 1,582.26 | 1,959.58 |
| Profit After Tax (PAT) | -40.54 | -4.88 | 70.68 |
| EBITDA | 168.82 | 190.45 | 309.4 |
| Total Assets | 2,553.87 | 2,989.2 | 3,641.34 |
| Net Worth | 2,629.52 | 2,681.02 | 2,752.52 |
| Reserves & Surplus | 1,073.12 | 1,135.71 | 1,150.74 |
| Total Borrowing | 556.54 | 813.1 | 1,729.46 |
Revenue & Profit Trend
The basis of allotment for Integris Medtech IPO is scheduled for 02 Dec 2026. You can check your allotment status using your PAN number or application number on the KFin Technologies Limited portal or BSE.
The Integris Medtech IPO is expected to open in Nov 2026, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Integris Medtech IPO is yet to be announced.
As per market sources, Integris Medtech IPO GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Integris Medtech IPO is being updated. Check the latest subscription figures by category (Retail, QIB, NII) for real-time updates.
The listing date for Integris Medtech IPO is 04 Dec 2026.
No comments yet. Be the first to comment!